| Product Code: ETC6666706 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Sexually Transmitted Diseases (STD) Testing Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Sexually Transmitted Diseases (STD) Testing Market - Industry Life Cycle |
3.4 Canada Sexually Transmitted Diseases (STD) Testing Market - Porter's Five Forces |
3.5 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume Share, By Location of Testing, 2021 & 2031F |
4 Canada Sexually Transmitted Diseases (STD) Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about the importance of regular STD testing |
4.2.2 Growing prevalence of STDs in Canada |
4.2.3 Technological advancements in testing methods for STDs |
4.3 Market Restraints |
4.3.1 Stigma associated with STD testing leading to hesitancy among individuals |
4.3.2 Lack of access to testing facilities, especially in remote areas |
4.3.3 Cost of STD testing and healthcare services |
5 Canada Sexually Transmitted Diseases (STD) Testing Market Trends |
6 Canada Sexually Transmitted Diseases (STD) Testing Market, By Types |
6.1 Canada Sexually Transmitted Diseases (STD) Testing Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Chlamydia, 2021- 2031F |
6.1.4 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Syphilis, 2021- 2031F |
6.1.5 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Gonorrhea, 2021- 2031F |
6.1.6 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.1.7 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Human Papilloma Virus, 2021- 2031F |
6.1.8 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Human Immunodeficiency Virus, 2021- 2031F |
6.2 Canada Sexually Transmitted Diseases (STD) Testing Market, By Location of Testing |
6.2.1 Overview and Analysis |
6.2.2 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Laboratory Testing, 2021- 2031F |
6.2.3 Canada Sexually Transmitted Diseases (STD) Testing Market Revenues & Volume, By Point of Care (POC) Testing, 2021- 2031F |
7 Canada Sexually Transmitted Diseases (STD) Testing Market Import-Export Trade Statistics |
7.1 Canada Sexually Transmitted Diseases (STD) Testing Market Export to Major Countries |
7.2 Canada Sexually Transmitted Diseases (STD) Testing Market Imports from Major Countries |
8 Canada Sexually Transmitted Diseases (STD) Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals getting tested for STDs annually |
8.2 Average waiting time for getting STD test results |
8.3 Number of new testing facilities or clinics offering STD testing services |
8.4 Rate of adoption of new testing technologies for STDs |
8.5 Percentage of population covered by public health programs offering free or subsidized STD testing |
9 Canada Sexually Transmitted Diseases (STD) Testing Market - Opportunity Assessment |
9.1 Canada Sexually Transmitted Diseases (STD) Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Canada Sexually Transmitted Diseases (STD) Testing Market Opportunity Assessment, By Location of Testing, 2021 & 2031F |
10 Canada Sexually Transmitted Diseases (STD) Testing Market - Competitive Landscape |
10.1 Canada Sexually Transmitted Diseases (STD) Testing Market Revenue Share, By Companies, 2024 |
10.2 Canada Sexually Transmitted Diseases (STD) Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here